Post-approval studies (Phase 4)Study completedNCT03646292
What this trial is testing
Antidiabetic Drugs for Steatotic Liver Disease
Who this might be right for
MASLD - Metabolic Dysfunction-Associated Steatotic Liver DiseaseType 2 DiabetesDigestive System Disease+11 more
Yonsei University 51